Not applicableEnded earlyNCT05252910What this trial is testingSpecimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and AdolescentsWho this might be right forCOVID-19 Pharm-Olam, LLC 33
Testing effectiveness (Phase 2)Temporarily pausedNCT05150496What this trial is testingImmunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in TurkeyWho this might be right forCOVID-19 Sinovac Research and Development Co., Ltd. 640
Large-scale testing (Phase 3)UnknownNCT05911061What this trial is testingA Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster VaccinationWho this might be right forCOVID-19 WestVac Biopharma Co., Ltd. 4,950
Not applicableStudy completedNCT05697705What this trial is testingEffectiveness of the Oxford-AstraZeneca COVID-19 Vaccine as a 2nd Booster, the REFORCO-Brazil StudyWho this might be right forCOVID-19 AstraZeneca 188,814,085
Post-approval studies (Phase 4)Active Not RecruitingNCT07287137What this trial is testingComparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) StudyWho this might be right forCOVID -19COVID - 19COVID 19+5 more Henry M. Jackson Foundation for the Advancement of Military Medicine 54
Not applicableStudy completedNCT05052307What this trial is testingA Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine in BrazilWho this might be right forCovid19 Hospital Moinhos de Vento 4,574
Post-approval studies (Phase 4)Study completedNCT05022472What this trial is testingProject 2VIDA! COVID-19 Vaccine Intervention Delivery for Adults in Southern CaliforniaWho this might be right forVaccine RefusalCovid19 Britt Skaathun 1,051
Early research (Phase 1)Study completedNCT06032000What this trial is testingEvaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)Who this might be right forCOVID-19 InfectionCOVID-19 Vaccine Adverse Reaction Lemonex 20
Not applicableStudy completedNCT04928911What this trial is testingExpectations About the COVID-19 VaccinesWho this might be right forVaccine Adverse Reaction University of Aarhus 1,176
Not applicableStudy completedNCT05515081What this trial is testingAntibody Response and Longevity Post SARS-CoV-2 Vaccine (SARS-AB)Who this might be right forVaccine Reaction IRCCS San Camillo, Venezia, Italy 200
Testing effectiveness (Phase 2)Study completedNCT05007509What this trial is testingSafety and Immunogenicity Study of Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Adult Healthy Volunteers (COVID-19)Who this might be right forCovid19SARS CoV 2 Infection Laboratorios Hipra, S.A. 30
Large-scale testing (Phase 3)Study completedNCT04652102What this trial is testingA Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and OlderWho this might be right forCovid19SARS-CoV-2 CureVac 39,680
Early research (Phase 1)Study completedNCT04816019What this trial is testingIntranasal ChAdOx1 nCOV-19Who this might be right forCoronavirus University of Oxford 42
Not applicableStudy completedNCT05057936What this trial is testingAntibody After COVID-19 VaccinationWho this might be right forCovid19Breakthrough InfectionCKD+2 more Bangkok Metropolitan Administration Medical College and Vajira Hospital 140
Testing effectiveness (Phase 2)WithdrawnNCT05013983What this trial is testingClinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and AdolescentsWho this might be right forCOVID-19 WestVac Biopharma Co., Ltd.
Testing effectiveness (Phase 2)Ended earlyNCT05016622What this trial is testingBooster Dose TrialWho this might be right forCancer Montefiore Medical Center 106
Testing effectiveness (Phase 2)Ended earlyNCT04276896What this trial is testingImmunity and Safety of Covid-19 Synthetic Minigene VaccineWho this might be right forPathogen Infection Covid-19 Infection Shenzhen Geno-Immune Medical Institute 100
Testing effectiveness (Phase 2)Ended earlyNCT04788459What this trial is testingSafety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult VolunteersWho this might be right forCOVID-19Protection Against COVID-19 and Infections With SARS-CoV- 2COVID-19 Immunisation Takis 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06919796What this trial is testingMRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery RoutesWho this might be right forEvaluate Immune Responses Following mRNA COVID-19 Vaccine Administration Through Different Delivery Routes in Healthy VolunteersSARS CoV-2 PharmaJet, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT05148091What this trial is testingThe Safety, Tolerability and Immunogenicity of COVID-19 Vaccine (SCTV01C) in Healthy, Unvaccinated AdultsWho this might be right forCOVID-19 Sinocelltech Ltd. 478